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Abstract
Background: Despite considerable international eHealth impetus, there is no guidance on the development of
online clinical care pathways. Advances in diagnostics now enable self-testing with home diagnosis, to which
comprehensive online clinical care could be linked, facilitating completely self-directed, remote care. We describe a
new framework for developing complex online clinical care pathways and its application to clinical management of
people with genital chlamydia infection, the commonest sexually transmitted infection (STI) in England.
Methods: Using the existing evidence-base, guidelines and examples from contemporary clinical practice, we developed
the eClinical Care Pathway Framework, a nine-step iterative process. Step 1: define the aims of the online pathway; Step 2:
define the functional units; Step 3: draft the clinical consultation; Step 4: expert review; Step 5: cognitive testing; Step 6:
user-centred interface testing; Step 7: specification development; Step 8: software testing, usability testing and further
comprehension testing; Step 9: piloting. We then applied the Framework to create a chlamydia online clinical care
pathway (Online Chlamydia Pathway).
Results: Use of the Framework elucidated content and structure of the care pathway and identified the need for
significant changes in sequences of care (Traditional: history, diagnosis, information versus Online: diagnosis, information,
history) and prescribing safety assessment. The Framework met the needs of complex STI management and enabled
development of a multi-faceted, fully-automated consultation.
Conclusion: The Framework provides a comprehensive structure on which complex online care pathways such
as those needed for STI management, which involve clinical services, public health surveillance functions and
third party (sexual partner) management, can be developed to meet national clinical and public health
standards. The Online Chlamydia Pathway’s standardised method of collecting data on demographics and
sexual behaviour, with potential for interoperability with surveillance systems, could be a powerful tool for
public health and clinical management.
Keywords: Online clinical care pathway, Framework, eHealth, Sexual health, Sexually transmitted infections,
Chlamydia trachomatis
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Background
In common with many other countries, UK has a promin-
ent eHealth agenda which prioritises self-led and remote
care [1–3]. Most eHealth to date has focused on monitor-
ing and management of long-term health conditions, such
as asthma, diabetes and hypertension, offered as an ad-
junct to traditional care [4–6]. Typically patients first re-
ceive their medical diagnosis from a healthcare
professional in a face-to-face consultation, with opportun-
ities to discuss their condition and its management, before
digital technologies such as apps for adherence, health
promotion and symptom diaries [4–20] are offered.
Analogous to home pregnancy testing, new infectious
disease diagnostic technology means that people will be
able to self-test for various infections at home and will be
able to self-diagnose with a new medical condition remote
from medical services. This could have considerable bene-
fits, particularly for people with stigmatizing infections such
as sexually transmitted infections (STIs) and HIV, as people
report barriers to accessing services and highly value acces-
sibility and convenience of medical care [21–25]. In
England, the major burden of STIs occurs in young people
[26]. This group has high smartphone and internet usage,
with 88 % of 16–24 year olds owning a smartphone, and
being rapid adopters of new technology [27].
The development of home STI diagnostics creates po-
tential for developing a completely remote online clinical
care pathway, from diagnosis through to management.
However, UK national standards for STI management
contain multiple facets of care [28] which are far more
complex than simply prescribing antibiotics. These in-
clude sexual partner management, health promotion,
sign-posting to other related services and collection of
data for routine public health surveillance purposes, whilst
maintaining data security and patient confidentiality [29].
All these elements would need to be incorporated within
an online care pathway for National Health Service use.
Currently there is no guidance in England on the devel-
opment and content of online clinical care pathways (‘struc-
tured multidisciplinary plans of anticipated care’ [30]), and,
in particular, no guidance specific to sexual health.
Here we describe a new framework for development of
complex online clinical care pathways (see Methods)
and demonstrate its utility for development of a system
for management of genital Chlamydia trachomatis infec-
tion (see Results), the commonest STI in England [26],
using an online automated clinical consultation followed
by remote prescribing and sexual partner management.
Methods
Development of the framework
Using the existing evidence base, guidelines and exam-
ples from contemporary clinical practice, we developed
the eClinical Care Pathway Framework. For the Online
Chlamydia Pathway, intended to take users, who have
tested using a variety of routes, from accessing test re-
sult, and therefore diagnosis, through automated medical
assessment and on to treatment, we undertook a com-
prehensive literature review of published and grey litera-
ture. We were unable to identify any validated tools or
methods to guide the development of a remote online
automated clinical care pathway. However, there was in-
formation available that could be used to indirectly in-
form the development of such a pathway. We
synthesised our findings to develop the Framework cre-
ating a nine-step iterative process (Fig. 1).
This included evidence on Step 1 (aims) [31, 32], Step 2
(pathway sequence) [33], Step 3 (online consultation) [34],
Step 4 (expert review) [34–36], Step 5 (cognitive testing)
[37–41], Step 6 (interface testing) [39, 42, 43], Step 8 (soft-
ware and usability testing) [32, 33, 35, 39, 44, 45] and Step
9 (pilot) [31, 35, 41].
Step 1 is to define the aims of the online clinical care
pathway. Step 2 requires definition of the functional
units by breaking down the clinical care pathway into
sections (for example history, examination and investiga-
tions (screening or diagnostic tests) based around the
traditional aspects of clinical care it contains. It is im-
portant to consider whether the sequence needs to be
different to traditional care. For example, in a traditional
clinical care pathway sequence where a patient comes
into clinic, the initial functional unit is the presenting
complaint and history of presenting complaint. In an on-
line clinical care pathway this may not be appropriate,
particularly if the pathway is linked to, for example, re-
mote self-testing and diagnosis.
Step 3 involves drafting the automated online clinical
consultation which is likely to be a key component of
most clinical care pathways. This is the “automated med-
ical assessment” which includes history-taking, decision-
making and easily extractable and transmissible surveil-
lance data. Composed of clinical and behavioural ques-
tions, it is designed to determine whether it is safe and
appropriate to proceed with remote management of the
condition. Relevant published literature, proformas and
protocols in contemporary use, standards and existing
services provide a robust evidence-base for the online
consultation.
Step 4 involves review of the draft consultation by
clinical experts with respect to the content, phrasing
and flow of questions and text. Any issues where it is
not possible to reach consensus as part of this
process can be focussed on as part of Step 5 and Step
6. Immediately following this it is important to ensure
that users comprehend and interpret the text and
questions correctly. This can be done by cognitively
testing [46] (Step 5) the text and questions with a
sample of your target population.
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Step 6 involves user-centred interface design and test-
ing. For user-centred interface design the question set is
translated into a format that works on the chosen screen
resolutions with the appropriate response options. It is
important to use relevant user interface design guide-
lines as a basis for this [42]. The purpose of testing is to
focus on the users’ views of the interface, how the infor-
mation is presented and the order of the interactive
steps in the user interface.
Step 7 requires conversion of the online clinical con-
sultation into a database specification in order for soft-
ware engineers to design the system according to one’s
needs. This process is described in more detail in the re-
sults section below and includes translation of the data-
base specification in to wireframes to specify the user
interface to achieve the optimal design output. Once the
software engineers have produced an application (app),
further expert usability review, software testing, usability
testing and comprehension testing can be conducted by
a clinical researcher and Human Computer Interface ex-
pert (Step 8). Finally, Step 9 involves piloting of the on-
line clinical care pathway with the target population,
with further refinement occurring on the basis of find-
ings and evaluation of this.
Application of the framework to chlamydia
Once the Framework was developed, we then applied it
to our exemplar condition, genital chlamydia to produce
the Online Chlamydia Pathway. Chlamydia is an ideal
candidate infection as it is common, and there is a
standard first line antibiotic therapy, Azithromycin 1 g
orally [47]. Azithromycin has good tolerability, a low
side-effect profile, and allergy and drug interactions are
infrequent among the target population [48–53].
This phase involved:
1. Sourcing of national and international clinical
standards for sexual history taking, chlamydia
management, health promotion, sexual health
service provision, consent, good medical practice,
and prescribing
2. Collation of protocols (‘a comprehensive set of rigid
criteria outlining the management steps for a single
clinical condition or aspects of organisation’ [30])
and proformas in use in contemporary sexual health
settings
3. Literature search for evidence on provision of STI
results and the individual components of the online
clinical consultation
4. Collation of sexual health questionnaires and
computer assisted structured interviews
Results and discussion
Step 1: Aim
The aim of the Online Chlamydia Pathway was to en-
able people with genital chlamydia to receive their
test result online, obtain information about the infec-
tion, complete a clinical consultation, and for those
for whom it was appropriate to do so, progress to re-
ceive a remote prescription of antibiotic treatment in
a safe, efficient manner. It also needed to ensure that
patients for whom it was not appropriate to be man-
aged in this way were identified and transferred to
traditional services in a timely and efficient manner.
Step 9: Piloting the online clinical care pathway
Step 8: Software testing, usability testing and further comprehension testing
Step 7: Specification development
Step 6: User-centred interface design & testing
Step 5: Cognitive testing
Step 4: Expert review
Step 3: Draft the online clinical consultation
Step 2: Define the functional units & their sequence within the clinical care 
pathway
Step 1:Define the aims of the online clinical care pathway
Fig. 1 eClinical Care Pathway Framework
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Further aims of the Online Chlamydia Pathway in-
cluded partner notification, provision of epidemio-
logical treatment where acceptable and appropriate
for sexual partners, a two-week health adviser follow-
up phone-call for all patients who accessed the online
clinical consultation, and collection of data for na-
tional surveillance system purposes.
Step 2: pathway sequence
Use of the Framework clarified the basic sequence of func-
tional units of care (Fig. 2), which is fundamentally differ-
ent to traditional care pathways which start with the
medical history, followed by examination, investigations,
results and management. Our pathway had to accommo-
date patients entering from different types of chlamydia
screening providers, each with different processes for, and
content of, medical information gathering and capture at
the time of testing, whilst keeping collection of patient
identifiable data to a minimum. This meant that there was
no patient history available at the point of diagnosis and
therefore this had to be taken once the patient was already
aware of the results of the investigations.
It is also possible that people may have developed new
symptoms in the time between testing and diagnosis, or
that they may be more candid in the face of a positive test
result, and it was therefore important to establish a history
specific to whether it was safe and appropriate to prescribe
Azithromycin without face-to-face clinical review. This was
a radical departure from traditional pathways and had
major implications in terms of the information that needed
to be provided and the content, phrasing, logic and order
of the questions asked in the clinical consultation.
Based on the online pathway sequence, the individual
functional units of the pathway were established (Fig. 3a
and b). As well as the points made above, the rationale
behind the order chosen included reducing the length of
the interaction for those whom it was not safe to treat.
In this way such patients could transfer to alternative
(face-to-face) care as quickly as possible, rather than
only finding this out at the end of the consultation.
Step 3: online consultation
The automated online clinical consultation consisted of
functional units one to nine, as shown in Fig. 3b. For each
of these units, the objective of the unit and evidence bases
for the unit were analysed, with a decision then being
made as to the optimal way of developing and implement-
ing that unit. The first functional unit was a results service
which required examination of the evidence base [54–67]
and current practice to conclude the best way for patients
to access their results. Information was collected within
the online clinical consultation on basic personal and
demographic details (required for both clinical needs and
surveillance purposes), taking relevant medical/drug his-
tory, symptom assessment, sexual history, risk assessment,
and partner notification with epidemiological treatment
[38, 43, 48, 51–53, 68–108].
Those patients for whom it was assessed to be safe and
appropriate were able to choose a local pharmacy from
where they could collect their treatment. A clinical help-
line was available to support patients’ medical and psycho-
social needs throughout this pathway. All patients who
consented [109] were followed up with a phone call from
a research health adviser at two weeks. A separate portal
was developed to support the research health adviser; this
included details and status of all eligible patients, details of
information entered onto the system by the results admin-
istrator and patient, a screen for documenting conversa-
tions via the clinical helpline, treatment outcomes and a
structured two week phone follow-up.
Step 4: expert review
The expert review panel consisted of consultant genito-
urinary medicine and public health physicians, aca-
demics in sexual health, public health, human computer
interaction, bioethics and a research health adviser.
Traditional clinical care pathway:
Online clinical care pathway:
History taken Examination
Investigations
(screening or 
diagnostic 
tests)
Results Management
Investigations
(screening or 
diagnostic 
tests)
Results History taken Management
Fig. 2 Contrast between the basic sequence of functional units of care in traditional clinical care pathways and online clinical care pathways
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Feedback from the panel led to amendments to the con-
tent and phrasing of the text and questions within the
online clinical consultation.
Step 5: cognitive testing
Beatty and Wallis define cognitive testing as ‘the admin-
istration of draft survey questions while collecting add-
itional verbal information about the survey response,
which is used to evaluate the quality of the response or
to help determine whether the question is generating the
information that its author intends’ [110]. Cognitive test-
ing was conducted with members of the public. One of
the main findings from this was that people either did
not know what azithromycin (a macrolide and first-line
treatment for chlamydia [93]) was or confused it with
erythromycin. This meant that they were unable to ac-
curately interpret and answer the question relating to al-
lergies. It was therefore necessary to develop a series of
questions which allowed patients with no allergies to
pass on to the next section whilst ensuring that any pa-
tients who were allergic to macrolides came off the on-
line pathway and into clinic.
Step 6: user-centred interface design and testing
Initial focus groups were conducted by a Human Com-
puter Interaction researcher in university and secondary
schools in order to establish user requirements [42]. User
interface design principles and guidelines were then used
to design the interface to ensure optimal display of ques-
tions and response sets, along with facilitating the user
journey and flow of interaction. Lab-based user interface
testing was conducted with wire-framed prototypes.
Step 7: specification development
A specification was developed in Microsoft Excel which
included text, logic, data item numbering, field names
and the export data sheet. This was sent to the software
engineers, along with the user interface design wire-
frames (which specified the look and feel of the interface
and clarified the user journey) for development of a
demonstration version of the pathway.
Step 8: software and usability testing
Further software, usability and cognitive testing was then
conducted with the demonstration version of the pathway
before the system went live. This included the Human
Computer Interaction researcher conducting an expert us-
ability review and lab-based testing with members of the
public, and repeated testing of the system to ensure that it
was accurate, fully functional and coded correctly.
Step 9: pilot
The Online Chlamydia Pathway has been successfully
piloted in an exploratory study involving patients re-
cruited from Sexual Health Clinics and the National
Chlamydia Screening Programme in England [111].
Conclusions
Despite the increasing uptake of eHealth within the NHS,
at present there is no guidance available on the develop-
ment of online clinical care pathways. There are funda-
mental differences between the approach taken with
online compared to traditional clinical care pathways.
These include the sequence of the pathway, which ques-
tions are asked and how the text is phrased, ensuring that
it is safe and appropriate for the patient to be managed
a b
Fig. 3 a Functional units of a traditional sexual health pathway. b Functional units of the Online Chlamydia Pathway
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online and providing an alternative rapid pathway into
care for those patients for whom it is not appropriate.
We developed a new framework for complex online
clinical care pathways and adapted it for use for manage-
ment of genital Chlamydia trachomatis infection. The
Framework is a useful structure for developing an online
clinical care pathway. We have used it here to develop a
complex online clinical care pathway for chlamydia
which provides the services, data collection, surveillance
function and standards a patient would have if attending
a traditional service, within an easy and acceptable for-
mat. This Online Chlamydia Pathway is compliant with
relevant standards and guidance. This is a new method
of developing an automated online clinical consultation
which is logical, comprehensive and aims to provide
users with the ability to choose the management path-
way which best suits them, and is most appropriate for
them, whilst maintaining a high standard of care. The
methodology used could be applied and adapted to a
wide range of conditions outside Sexual Health.
We have focused here on a common treatable bacterial
STI (Chlamydia trachomatis). However, the pathway
could be adapted to incorporate testing and managing
other STIs, and other services. Indeed, study patients re-
ceived negative results via the Online Chlamydia Path-
way results service for other STI tests they had in clinic.
As well as potentially reducing the time to treatment for
index patients, and increasing the proportion of patients
treated appropriately within the community, this stan-
dardised method of collecting data on demographics and
sexual behaviour, with easily extractable data and the po-
tential for interoperability with surveillance systems,
could be a powerful tool for public health and clinical
care. In order to complete this type of process effectively
requires effective multi-disciplinary collaboration.
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